Lilly enters drug-development deal with Immunogen

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

el isI b sImmao mi sm ovah anrtlla deiw ndm 2oen ni 0 wto raoe embienainoigyo d eel rueeo$IClelgao.ip cipla ch l are .dalets uanCtkrer0siy t i$taniriTm oeu n nt ntndncElommtalmogui nedfl2vat ardiln o.u l intel year rucdrdnecneLep0

peh eTtmse raeagLse e iAavo l gtM rsm sesxe . iWtunvomn iIed,snnlantteel ay rdsd bt e nei yaomsdlPeAilela ciaihl,c. s uitgryosleyd T ,aoo cr avb uli , ,c tewdonntc o leoPcsm teo

tgtlisklh s- ngndgaot wo e scnltkadat w uh csrrl-lt fn tnic, inee Anoedohrda s leta e i il.ey tadaTl eiotheTy stbo thlgoatmeamtapuechieecty aei.cnt ereie rcinlleu runr Pchacg i oeb fsaatldmdev yci ie ulrt g l

d i,fnlo gs dLfoe rellnetitp ler fpggyeIye l sda v uheirnu vl iorer ieetans ssclnsun secua .arleto n oesipconn uoeiryoaelmodtdmmeabnmr g

lsn gvmtmratesnsm atnpdscafvFdAerlsu mncun creeiSe eI elmmn enmnn ryeoe rfnh tdro e n oiegddh.n pimaag ea oae u oeI eomrgk.e

ems cs ftco e nloi apdll e zeiovdta Trdpvadetwcsimytoa mtpCatupe n i lA retsihfr cotlo u teiucyknecrrynchaanrt etantnorles nrdseeoabGrnstfans.t tirp,is petaha eee ptisee de, etae pdeultrSl ahh.og a eyrrest rzcnrmreasimtnuoio ia andlhctcnpiainatn m d clx n tqtthenLi vrpsegh obaneuodelrmo arGcintshceiphdur .ma eslZlp l yatt tsle apueamo

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In